Amgen Late To Raise Double-Taxation Claim, Tax Court Told
Biotechnology giant Amgen is making a "futile" attempt to raise a purported double-taxation issue for tax years 2016 through 2018 in a pair of transfer pricing cases before the U.S. Tax...To view the full article, register now.
Already a subscriber? Click here to view full article